Pay in 4 interest-free payments of $5.81 Learn more
Ships within 48 hours · Estimated delivery Sep 1 - Sep 6
Pape J, Paraskevopoulos E, Bruchmann M, Wollbrink A, Rudack C, Pantev C
Laboratory monitoring (CBC, CRP, kidney function) and possibly fecal calprotectin testing may help distinguish between medication side effects and disease flares
Last Published 05.01.2026 Effective Date: 05.01.2026 This policy addresses the use of Crysvita (burosumab-twza) for the treatment of X-linked hypophosphatemia (XLH) and Fibroblast Growth Factor 23 (FGF23)-related hypophosphatemia in tumor-induced osteomalacia (TIO)
Additionally, do not forget to consult with your healthcare provider regarding the cost and insurance coverage of Mounjaro after the switch
Note: Published safety data for TB-500 specifically is limitedmost evidence comes from Thymosin Beta-4 studies
US$ 27.87
US$ 26.13
US$ 23.48
US$ 27.68
US$ 27.28
